Apr 19, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me SalioGen Therapeutics, a biotechnology company developing therapies for a broad range of conditions, including inherited retinal diseases, has announced development of SGT-1001,...
Feb 1, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Ascidian Therapeutics has received authorization from the US Food & Drug Administration to launch a Phase ½ clinical trial for ACDN-01, the company’s RNA editing therapy for...
